Gunilla Osswald
Chief Executive Officer
Medicine
BioArctic
Sweden
Biography
Gunilla Osswald has extensive experience in drug development (30 years) and has successfully brought projects from preclinical development all the way to regulatory approval and market introduction. She has also successfully managed in- and outlicensing of drug projects. Osswald was for many years active in leading positions at AstraZeneca including Vice President responsible for developing AstraZeneca’s product portfolio in neurodegenerative diseases.Pharmacist and Doctor in biopharmacy and pharmacokinetics at Uppsala University.
Research Interest
Gunilla Osswald is board member of PledPharma AB (publ) and SpineMedical AB and deputy board member of LPB Sweden AB and LPB Sweden Holding AB.During the past five years Gunilla Osswald has been board member of SP Process Development AB and SpineMedical Sverige AB.